Global Skin Biopsy Market
Market Size in USD Billion
CAGR :
%

![]() |
2025 –2032 |
![]() |
USD 568.78 Million |
![]() |
USD 1,084.36 Million |
![]() |
|
![]() |
Global Skin Biopsy Market Segmentation, By Type (Shave Biopsy, Punch Biopsy, Excisional Biopsy, and Incisional Biopsy), Device (Needle Based Biopsy Guns, Biopsy Curettes and Punches, Guidance Systems, Biopsy Forceps, Biopsy Needles and Others), Indication (Actinic Keratosis, DermatitisPsoriasis, Skin Infection, Cancer, and Others), End User (Hospitals, Dermatology Clinics, and Others) – Industry Trends and Forecast to 2032
Skin Biopsy Market Analysis
The skin biopsy market is witnessing steady growth due to the rising incidence of skin diseases, including cancer, infections, and dermatitis. A skin biopsy is a crucial diagnostic tool to identify and evaluate various skin conditions by removing a sample of skin tissue for examination. With technological advancements in biopsy techniques, such as minimally invasive procedures and improved diagnostic accuracy, the market is poised for expansion. Recent developments have seen the introduction of innovative biopsy devices, such as needle-based biopsy guns and advanced guidance systems, enhancing the precision and efficiency of the procedure. Moreover, increasing awareness about early diagnosis of skin cancer and other dermatological conditions, coupled with advancements in healthcare infrastructure, is driving the market growth. Hospitals, dermatology clinics, and research institutions are the key end users of skin biopsy devices, leading to a surge in demand globally.
Skin Biopsy Market Size
The global skin biopsy market size was valued at USD 568.78 million in 2024 and is projected to reach USD 1084.36 million by 2032, with a CAGR of 8.40% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Skin Biopsy Market Trends
“Shift Towards Minimally Invasive Techniques”
The skin biopsy market is evolving with innovative advancements aimed at improving diagnostic accuracy and patient comfort. A major trend is the shift towards minimally invasive techniques, with technologies such as punch biopsies and needle-based biopsy guns becoming increasingly popular. These advancements reduce patient recovery time and procedural pain while ensuring reliable results. In addition, digital pathology and AI-driven diagnostic tools are gaining traction, enhancing the ability to analyze biopsy samples quickly and accurately. The growing prevalence of skin cancer and other dermatological conditions, alongside innovations in biopsy devices, is driving market growth. As healthcare infrastructure improves and awareness of early skin disease detection rises, the market continues to expand.
Report Scope and Skin Biopsy Market Segmentation
Attributes |
Skin Biopsy Key Market Insights |
Segments Covered |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
Key Market Players |
BD (U.S.), Boston Scientific Corporation (U.S.), Cook (U.S.), DTR Medical Ltd (U.K.), Devicor Medical Products, Inc. (U.S.), Leica Biosystems Nussloch GmbH (Germany), Hologic, Inc. (U.S.), Cardinal Health (U.S.), Danaher (U.S.), innoMedicus (Germany), Intuitive Surgical (U.S.), CANON MEDICAL SYSTEMS CORPORATION (Japan), iSYS Medizintechnik GmbH (Germany), Biosystems, Inc. (U.S.) |
Market Opportunities |
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. |
Skin Biopsy Market Definition
A skin biopsy is a medical procedure in which a small sample of skin tissue is removed for examination to diagnose or evaluate various skin conditions. It is commonly used to detect skin cancers (such as melanoma or basal cell carcinoma), infections, rashes, and inflammatory skin diseases. There are several types of skin biopsies, including shave, punch, excisional, and incisional biopsies, each chosen based on the condition being investigated. The collected tissue sample is then examined under a microscope by a pathologist to help determine the cause of symptoms and guide appropriate treatment.
Skin Biopsy Market Dynamics
Drivers
- Rising Incidence of Skin Diseases
The rising prevalence of skin cancer, including melanoma and non-melanoma types, alongside other common dermatological conditions such as dermatitis and psoriasis, is significantly driving the demand for skin biopsy procedures. As skin cancers become more widespread, early diagnosis through biopsy becomes essential for effective treatment and management. With skin biopsies being a critical diagnostic tool, their demand is increasing as individuals seek medical evaluation for suspicious skin lesions or symptoms. In addition, the growing awareness of the importance of timely diagnosis of skin conditions is further contributing to the market expansion for skin biopsy procedures, making them a key driver in this market.
- Increased Awareness and Early Detection
Increasing awareness about the significance of early diagnosis for skin cancers, such as melanoma, and other skin disorders is a major driver of the skin biopsy market. As people become more informed about the risks of undiagnosed skin conditions and the potential for early intervention, they are more likely to seek biopsy procedures to detect abnormalities at an early stage. This growing awareness is leading to more people proactively visiting dermatologists for evaluation, which is increasing demand for skin biopsies. With early diagnosis playing a crucial role in effective treatment and better patient outcomes, the heightened awareness is significantly boosting the market.
Opportunities
- Development of Advanced Biopsy Technologies
The development of advanced technologies such as digital pathology, AI-based analysis, and minimally invasive biopsy devices presents significant growth opportunities for the skin biopsy market. These innovations are transforming how skin biopsies are performed, offering enhanced diagnostic accuracy by enabling faster and more precise identification of abnormalities. In addition, minimally invasive devices reduce procedure-related pain and discomfort for patients, improving the overall patient experience and recovery time. As these technologies become more widely available and adopted, they are expected to drive greater demand for skin biopsy procedures, making them a key market opportunity for industry players to explore and capitalize on.
- Non-invasive Alternatives
With the growing demand for non-invasive and less painful diagnostic methods, companies in the skin biopsy market have a significant opportunity to innovate and introduce alternatives to traditional biopsy techniques. Non-invasive options such as liquid biopsies, which involve analyzing blood or other bodily fluids for cancer markers, and optical diagnostic methods, such as advanced imaging techniques, are gaining attention as potential alternatives. These methods offer patients a more comfortable experience and can reduce procedure-associated risks. As these technologies evolve and gain approval, they present an exciting opportunity for companies to capture a new market segment, expanding their customer base while addressing the increasing preference for minimally invasive diagnostic solutions.
Restraints/Challenges
- Complications from Biopsy Procedures
While skin biopsy procedures are generally considered safe, there are inherent risks and complications that can occur, such as infection, scarring, or improper wound healing. These potential risks can cause discomfort for patients and may lead to concerns about the procedure's safety, ultimately deterring some individuals from opting for a biopsy. This reluctance to undergo the procedure can limit the overall demand for skin biopsy services, especially in patients with sensitive skin or those who are apprehensive about the possibility of adverse effects. As a result, these risks pose a challenge to the growth of the skin biopsy market by reducing patient willingness to undergo biopsies.
- High Costs of Advanced Technologies
The high cost of advanced biopsy technologies, such as digital pathology systems and AI-based diagnostic tools, presents a significant barrier to their widespread adoption. These technologies require substantial investment, making them less accessible, particularly in low-income regions and healthcare settings with limited financial resources. The upfront cost of acquiring and maintaining such advanced equipment can limit its availability, restricting access to the latest diagnostic methods for patients who may benefit from them. Consequently, this financial barrier hinders market growth and slows the transition to more efficient, accurate, and minimally invasive diagnostic technologies, especially in underfunded healthcare environments.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Skin Biopsy Market Scope
The market is segmented on the basis of type, device, indication, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Shave Biopsy
- Punch Biopsy
- Excisional Biopsy
- Incisional Biopsy
Device
- Needle Based Biopsy Guns
- Biopsy Curettes and Punches
- Guidance Systems
- Biopsy Forceps
- Biopsy Needles
- Others
Indication
- Actinic Keratosis
- Dermatitis
- Psoriasis
- Skin Infection
- Cancer
- Others
End User
- Hospitals
- Dermatology Clinics
- Others
Skin Biopsy Market Regional Analysis
The market is analysed and market size insights and trends are provided by country, type, device, indication, and end user as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominate the largest share of the skin biopsy market due to the rising prevalence of cancer, particularly skin cancer. The region benefits from the growing adoption of technologically advanced, minimally invasive biopsy procedures, along with increasing awareness of cancer screening programs. In addition, the availability of early diagnostic procedures further supports market growth in North America.
Asia-Pacific is projected to experience the highest growth in the skin biopsy market from 2025 to 2032. This growth is fueled by rising healthcare expenditure, government initiatives supporting medical advancements, and the availability of advanced smart biopsy devices. In addition, increasing awareness campaigns about cancer in the region are expected to further drive market expansion.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Skin Biopsy Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Skin Biopsy Market Leaders Operating in the Market Are:
- BD (U.S.)
- Boston Scientific Corporation (U.S.)
- Cook (U.S.)
- DTR Medical Ltd (U.K.)
- Devicor Medical Products, Inc. (U.S.)
- Leica Biosystems Nussloch GmbH (Germany)
- Hologic, Inc. (U.S.)
- Cardinal Health (U.S.)
- Danaher (U.S.)
- innoMedicus (Germany)
- Intuitive Surgical (U.S.)
- CANON MEDICAL SYSTEMS CORPORATION (Japan)
- iSYS Medizintechnik GmbH (Germany)
- Biosystems, Inc. (U.S.)
Latest Developments in Skin Biopsy Market
- In May 2023, Argon Medical Devices, Inc. launched the SuperCore Advantage Semi-Automatic Biopsy instrument, expanding its portfolio of soft tissue biopsy products in the U.S. This addition aims to enhance biopsy procedures with improved precision and efficiency
- In April 2023, GE Healthcare unveiled the bkActiv system, a cutting-edge ultrasound imaging tool for surgical applications, designed to empower surgeons with accurate, real-time imaging to support better decision-making during procedures
- In January 2023, GE Healthcare completed the acquisition of IMACTIS, a France-based company specializing in CT navigation products. This acquisition is set to enhance GE Healthcare's offerings, with IMACTIS' technology already approved for use in Europe and the U.S.
- In May 2022, Terumo India partnered with Argon Medical to strengthen its position in the Indian market. The partnership enabled Terumo to offer a comprehensive range of advanced medical solutions, including biopsy tools and treatments for deep vein thrombosis
- In June 2020, Innovia Medical expanded its manufacturing capacity for cervical rotating biopsy punches to address the growing demand for cancer diagnoses. This move was aimed at meeting the increased need for diagnostic tools in cancer detection. By scaling up production, Innovia Medical sought to support healthcare providers with enhanced biopsy solutions
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.